{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:55:31Z","timestamp":1784332531557,"version":"3.55.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.7759\/cureus.16137","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T13:11:52Z","timestamp":1625317912000},"source":"Crossref","is-referenced-by-count":5,"title":["The Addition of Montelukast for the Treatment of Chronic Idiopathic Urticaria"],"prefix":"10.7759","author":[{"given":"Salim","family":"Alkeraye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danah K","family":"AlRuhaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/187152812800392742","article-title":"Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria","volume":"11","author":"Khan S","year":"2012","unstructured":"Khan S, Lynch N. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria. Inflamm Allergy Drug Targets. 2012, 11:235-43. 10.2174\/187152812800392742","journal-title":"Inflamm Allergy Drug Targets"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.10.1337","article-title":"Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine","volume":"142","author":"McGirt LY","year":"2006","unstructured":"McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol. 2006, 142:1337-42. 10.1001\/archderm.142.10.1337","journal-title":"Arch Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_551_16","article-title":"Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: a double-blind, randomized, controlled trial","volume":"83","author":"Sarkar TK","year":"2017","unstructured":"Sarkar TK, Sil A, Pal S, Ghosh C, Das NK. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: a double-blind, randomized, controlled trial. Indian J Dermatol Venereol Leprol. 2017, 83:561-8. 10.4103\/ijdvl.IJDVL_551_16","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1329505","article-title":"Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence","volume":"29","author":"Holm JG","year":"2018","unstructured":"Holm JG, Ivyanskiy I, Thomsen SF. Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence. J Dermatolog Treat. 2018, 29:80-97. 10.1080\/09546634.2017.1329505","journal-title":"J Dermatolog Treat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.04.026","article-title":"Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria","volume":"6","author":"Akenroye AT","year":"2018","unstructured":"Akenroye AT, McEwan C, Saini SS. Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2018, 6:1403-5. 10.1016\/j.jaip.2018.04.026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref6","unstructured":"Montelukast FDA label. (1998). Accessed. April 1, 2020: http:\/\/2.amazonaws.com\/drugbank\/cite_this\/attachments\/files\/000\/001\/928\/original\/FDA_label_montelukast.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.126676","article-title":"The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study","volume":"110","author":"Erbagci Z","year":"2002","unstructured":"Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol. 2002, 110:484-8. 10.1067\/mai.2002.126676","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.002","article-title":"The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results","volume":"113","author":"Bagenstose SE","year":"2004","unstructured":"Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol. 2004, 113:134-40. 10.1016\/j.jaci.2003.10.002","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(11)70018-X","article-title":"Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria","volume":"105 Suppl 1","author":"Kosnik M","year":"2011","unstructured":"Kosnik M, Subic T. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria. Respir Med. 2011, 105 Suppl 1:S84-8. 10.1016\/S0954-6111(11)70018-X","journal-title":"Respir Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63505-the-addition-of-montelukast-for-the-treatment-of-chronic-idiopathic-urticaria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:39Z","timestamp":1707507099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63505-the-addition-of-montelukast-for-the-treatment-of-chronic-idiopathic-urticaria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.16137","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,3]]}}}